EVOLENT HEALTH INC - NOTE 2.000%12/0

CUSIP: 30050BAB7

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Debt / NOTE 2.000%12/0
Market price (% of par)
87.55%
Total 13F principal
$71,976,420
Principal change
+$4,017,333
Total reported market value
$66,016,000
Number of holders
15
Value change
+$1,677,379
Number of buys
6
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 30050BAB7?
CUSIP 30050BAB7 identifies 30050BAB7 - EVOLENT HEALTH INC - NOTE 2.000%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOLENT HEALTH INC - NOTE 2.000%12/0 as of Q3 2019

As of 30 Sep 2019, EVOLENT HEALTH INC - NOTE 2.000%12/0 was held by 15 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $71,976,420 in principal (par value) of the bond. The largest 10 bondholders included Allianz Asset Management GmbH, Birch Grove Capital LP, SOROS FUND MANAGEMENT LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, Altium Wealth Management LLC, Linden Advisors LP, BLAIR WILLIAM & CO/IL, and BARCLAYS PLC. This page lists 15 institutional bondholders reporting positions for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.